John Ligon

Assistant Professor · University of Florida

Dr. John Ligon is a translational researcher committed to advancing novel cellular therapies and immunotherapies.

Cancer Cancer Immunotherapy Clinical Trials Developmental Therapeutics Oncology

Qin Wang, PhD

Professor of Neuroscience & Regenerative Medicine · Augusta University

Qin Wang researches the neuropharmacology and signaling mechanisms underlying neurological and psychiatric disorders.

Neurological Disorders Regenerative Medicine Molecular Neuropharmacology Neuroscience Neuropharmacology

Philip Santangelo

Professor, Biomedical Engineering · Georgia Tech - COE

Philip J. Santangelo researches optical microscopy and in vivo imaging, RNA virus pathogenesis, HIV/SIV.

Therapeutics and Vaccines RNA Regulation RNA Virus Pathogenesis Optical Microscopy and In Vivo Imaging HIV/SIV and hRSV

Lisa Holle, Pharm.D., BCOP, FHOPA

Associate Clinical Professor of Pharmacy Practice · University of Connecticut

Dr. Holle’s clinical research focuses on medical marijuana, oral cancer therapy management, and impact of clinical pharmacy services

MyDispense Medical Marijuana Pain Cancer Cancer Therapeutics

Locke Bryan, PhD

Medical Hematologist-Oncologist · Georgia Cancer Center at Augusta University

A leading medical hematologist-oncologist who also specializes in Lymphomas Immunotherapy Novel Therapeutics.

Lymphomas Immunotherapy Novel Therapeutics

Michael H. Peters, Ph.D.

Professor, Department of Chemical and Life Science Engineering · VCU College of Engineering

Professor Peters conducts experimental and theoretical research in the field of protein engineering.

Peptidyl-Biomimetics Inhibitors for Breast Cancer Targets OpenContact: A Simple Static Protein-Protein Mapping Algorithm Extended Liouville Equation for Open Systems Neuronal Stem Cell Delivery Systems Protein Engineering

Elisabeth Barton

Professor/Associate Dean · University of Florida

Elisabeth Barton is a molecular physiologist with a primary interest in skeletal muscle repair.

Space Viral Gene Therapy Optimization of IGF-I for Muscle Therapeutics Mechanical Signal Transduction Skeletal Muscle Repair

Gerry Brunk

Managing Director · Lumira Ventures

Gerry Brunk is a venture capital investor with expertise in biotechnology, medical devices, start-ups and corporate strategy.

Business Strategy Medical Devices Pharmaceutical Industry Drug Development Commercialization

C. Nataraj, PhD

Moritz Endowed Professor of Engineered Systems; Director, VCADS Research Center | College of Engineering · Villanova University

C. Nataraj, PhD, is an expert in unmanned vehicles, robotics, and diagnostic healthcare systems.

Autonomous Vehicles Unmanned Vehicles Robotics Drones Engineering

Bruce Armitage

Professor and Co-Director · Carnegie Mellon University

Bruce Armitage’s current research interests include the use of PNA for sequence-specific recognition of DNA and RNA.

Peptide Nucleic Acids DNA Nanotechnology Bioorganic Chemistry Fluorescent Dyes Molecular Evolution

John McCulloch

Founder & Managing Director · Burloch Group Inc.

Engaging and knowledgeable speaker with deep expertise in biotechnology investment.

Biotechnology Pharmaceuticals Innovation Investment

Robert Lanza

Scientist · Ocata Therapeutics

Robert Lanza is currently Chief Scientific Officer at Ocata Therapeutics and Adjunct Professor at Wake Forest University School of Medicine.

biocentrism Science Research Regenerative Medicine

Riccardo Panicucci

Senior VP CMC · QED Therapeutics and Origin Biosciences

Riccardo Panicucci is an expert in the pharmaceutical industry, biotechnology, clinical development, and biopharmaceuticals.

Technology Transfer Biotechnology Clinical Development Drug Discovery Drug Development

Dr. Mark Ware

Chief Medical Officer · Canopy Growth

Dr. Ware leads Canopy Growth’s medical division, Spectrum Therapeutics including research towards the development of cannabinoid medicines.

Endocannabinoid System Cannabis Research Cannabinoids Medical Cannabis Clinical Research

Avak Kahvejian

Partner, VentureLabs · Flagship Pioneering

Avak Kahvejian is an expert in conceiving and launching internally generated platform companies and leveraging new biological mechanisms.

Biotechnologies Design Biology Technology Biological Mechanisms

Emily Walsh

Principal Consultant · Halloran Consulting Group, Inc.

Recovering Scientist

Personalized Medicine and Genetics Translational Medicine Transitioning From the Bench Project Management 101 Program Management 101

Andrew Lover

Assistant Professor of Epidemiology and and Deputy Director, New England Center of Excellence in Vector-Borne Disease · University of Massachusetts Amherst

Andrew Lover is an infectious disease epidemiologist whose work focuses on malaria and other vector-borne diseases.

Tick-borne Diseases Infectious Disease Vector-Borne Diseases Drug Development Malaria

Robert Kemp

VP of Market Access and HEOR · Breath Therapeutics

Robert Kemp is an expert at developing value strategies using clinical and economic information.

Health Plans Health Informatics Medical Device Outcomes Research Strategic Leadership

Paulina Hill

Principal · Omega Funds

Paulina Hill is a healthcare investor who has expertise in biotechnology, molecular biology, cell culture and entrepreneurship.

Venture Capital Chemistry Technology Transfer Biochemistry Lifesciences

Gordon Mitchell

Professor & Director · University of Florida

Gordon Mitchell is a preeminence professor of neuroscience in the department of physical therapy and McKnight Brain Institute.

Cellular mechanisms of intermittent hypoxia induced spinal respiratory motor plasticity Compensatory respiratory plasticity in motor neuron disease (ALS) Inflammation and spinal plasticity Developmental plasticity Intermittent hypoxia and brain function